CXCL11 and hypoparathyroidism-retardation-dysmorphism syndrome: Furthermore, epithelial cells of HRD tumors could excrete a variety of immune chemokines such as CXCL8, CXCL10, and CXCL11 to recruit anti-tumor immune cells, suggesting an active immune response in the TME of HRD cancers [45].